To The Main Page
About RTC Stem Cell Therapy Research Translation Service/Technology Transfer Contact
 
 

The Reference and Translation Center for Cardiac Stem Cell Therapy (RTC) was founded in 2008 on the initiative of Prof. Dr. Gustav Steinhoff, heart surgeon and scientist at the University Medical Center Rostock, as one of the five translation centers for regenerative medicine in Germany which are funded by both by the federal and the state government. The RTC is hosted by the Biomedical Research Center (BMFZ) Rostock.

At the RTC high-performance medicine is being conducted. With focus on cardiovascular diseases innovative approaches for stem cell therapies are being developed in labs applying most modern molecular- and cell biological investigation methods and evaluating them in animal models – frequently in cooperation with industry partners.  Following the demonstration of safety and efficacy in the clinical study center of the RTC the new therapies are being integrated into the patient care activities of the Clinic for Heart Surgery.

The concept of the RTC includes all translation steps in the scope of both development and manufacturing of stem cell products as well as treatment of patients in a standardized and quality-assured manner according to the legal requirements of “Advanced Therapy Medicinal Products”. Accordingly, the RTC takes the position as a reference centre.

 

 

 

 

 


 

News

RTC-Seminar at the 16th of Juni 2015

Purinerges Signaling an
T-Zellen und epikardialen Stammzellen nach Myokardinfarkt

 

 

 

 

 

 

 

 

Seven years after the foundation of the Reference and Translation Center for Cardiac Stem Cell Therapy (RTC) at the University Medical Center Rostock  the actual RTC-Report 2008-2014 entitled “The regrowing heart” is now available.
 RTC Report 2008-2014 (English) 

 

     
   

 

Legal The RTC is supported by the BMBF and the State Mecklenburg-Western Pomerania using EU Structural Funds.